International Urology and Nephrology

, Volume 51, Issue 2, pp 231–238 | Cite as

The effects of oxytocin on penile tissues in experimental priapism model in rats

  • Engin KolukcuEmail author
  • Sahin Kilic
  • Bekir Suha Parlaktas
  • Fikret Erdemir
  • Velid Unsal
  • Dogan Atılgan
  • Nihat Uluocak
Urology - Original Paper



This study aimed to demonstrate the effects of oxytocin on penile tissues in ischemia–reperfusion injury developed after priapism.


Forty Wistar Albino strain male rats were divided into four groups. The control group (n = 10) was not intervened. In Group 2, a rat model of priapism was constructed and maintained for 1 h. In Group 3, reperfusion was ensured for 30 min following priapism. Rats in Group 4 rats were given oxytocin 30 min before the induction of reperfusion following priapism. All rats were penectomized, and adequate amounts of blood sample were drawn. Inflammation, vasocongestion, desquamation, and edema in penile tissue were scored between 0 and 3 points (0: normal, 1: mild, 2: moderate, 3: severe) to evaluate the severity of tissue damage. The activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), and the levels of malondialdehyde (MDA), and nitric oxide (NO) in blood samples were determined spectrophotometrically.


In histopathological examination, statistically significant positive changes were detected in vasocongestion, inflammation, desquamation, and edema scores in Group 4 than in Group 2 and Group 3 (p < 0.001). Biochemical test results revealed that NO levels were significantly lower in Group 4 than in Group 3 (p < 0.001). Serum GSH-Px activities in Group 4 significantly increased when compared with the other groups 2 and 3 (p = 0.002, p = 0.001, respectively). There was no statistical difference among the groups regarding SOD activities and MDA levels (p > 0.05).


Oxytocin protected against priapism-induced ischemia–reperfusion injury developed in cavernosal tissue as observed based on histopathological and biochemical evidence. Although this is an experimental study, oxytocin can be thought as an alternative drug in the treatment of priapism.


Ischemia–reperfusion injury Oxytocin Penile tissue Priapism Rat model 


Compliance with ethical standards

Conflict of interest

The authors report no conflict of interest.


  1. 1.
    Papadopoulos I, Kelami A (1988) Priapus and priapism. From mythology to medicine. Urology 32:385–386. CrossRefGoogle Scholar
  2. 2.
    Pryor J, Akkus E, Alter G et al (2004) Priapism. J Sex Med 1:116–120. CrossRefGoogle Scholar
  3. 3.
    Eland IA, van der Lei J, Stricker BH, Sturkenboom MJ (2001) Incidence of priapism in the general population. Urology 57:970–972. CrossRefGoogle Scholar
  4. 4.
    Munnariz R, Park K, Huang YH et al (2003) Reperfusion of ischemic corporal tissue: physiologic and biochemical changes in an animal model of ischemic priapism. Urology 62:760–764. CrossRefGoogle Scholar
  5. 5.
    Erkanli Senturk G, Erkanli K, Aydin U et al (2013) The protective effect of oxytocin on ischemia/reperfusion injury in rat urinary bladder. Peptides 40:82–88. CrossRefGoogle Scholar
  6. 6.
    Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407–421. CrossRefGoogle Scholar
  7. 7.
    Ciftci O, Oguz F, Beytur A, Polat F, Altıntas R, Oguzturk H (2014) Lycopene prevents experimental priapism against oxidative and nitrosative damage. Eur Rev Med Pharmacol Sci 18:3320–3325Google Scholar
  8. 8.
    Huang YC, Harraz AM, Shindel AW, Lue TF (2009) Evaluation and management of priapism: 2009 update. Nat Rev Urol 6:262–271. CrossRefGoogle Scholar
  9. 9.
    Erdemir F, Firat F, Markoc F et al (2014) The effect of pentoxifylline on penile cavernosal tissues in ischemic priapism-induced rat model. Int Urol Nephrol 46:1961–1967. CrossRefGoogle Scholar
  10. 10.
    Thackare H, Nicholson HD, Whittington K (2006) Oxytocin-its role in male reproduction and new potential therapeutic uses. Hum Reprod Update 12:437–448. CrossRefGoogle Scholar
  11. 11.
    Sanli O, Armagan A, Kandirali E et al (2004) TGF-β 1 neutralizing antibodies decrease the fibrotic effects of ischemic priapism. Int J Impot Res 16:492–497. CrossRefGoogle Scholar
  12. 12.
    Karaguzel E, Bayraktar C, Kutlu O et al (2016) The possible protective effects of dipyridamole on ischemic reperfusion injury of priapism. Int Braz J Urol 42:146–153. CrossRefGoogle Scholar
  13. 13.
    Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500Google Scholar
  14. 14.
    Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169Google Scholar
  15. 15.
    Mueller AR, Platz KP, Langrehr JM et al (1994) The effects of administration of nitric oxide inhibitors during small bowel preservation and reperfusion. Transplatation 58:1309–1316CrossRefGoogle Scholar
  16. 16.
    Hassanipour M, Amini-Khoei H, Shafaroodi H et al (2016) Atorvastatin attenuates the antinociceptive tolerance of morphine via nitric oxide dependent pathway in male mice. Brain Res Bull 125:173–180. CrossRefGoogle Scholar
  17. 17.
    Levey HR, Segal RL, Bivalacqua TJ (2014) Management of priapism: an update for clinicians. Ther Adv Urol 6:230–244. CrossRefGoogle Scholar
  18. 18.
    Spycher MA, Hauri D (1986) The ultastructure of the erectile tissue in priapism. J Urol 135:142–147CrossRefGoogle Scholar
  19. 19.
    Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R (2010) Priapism: pathogenesis, epidemiology, and management. J Sex Med 7:476–500. CrossRefGoogle Scholar
  20. 20.
    Jennings RB, Reimer KA (1991) The cell biology of acute myocardial ischemia. Annu Rev Med 42:225–246. CrossRefGoogle Scholar
  21. 21.
    Green CJ, Gower JD, Healing G, Cotterill LA, Fuller BJ, Simpkin S (1989) The importance of iron, calcium and free radicals in reperfusion injury: an overview of studies in ischaemic rabbit kidneys. Free Radic Res 7:255–264. Google Scholar
  22. 22.
    Nieuwenhuijs VB, De Bruijn MT, Padbury RT, Barritt GJ (2006) Hepatic ischemia-reperfusion injury: roles of Ca2+ and other intracellular mediators of impaired bile flow and hepatocyte damage. Dig Dis Sci 51:1087–1102. CrossRefGoogle Scholar
  23. 23.
    Chatauret N, Badet L, Barrou B, Hauet T (2014) Ischemia-reperfusion: from cell biology to acute kidney injury. Prog Urol 24:4–12. CrossRefGoogle Scholar
  24. 24.
    Kucukdurmaz F, Kucukgergin C, Akman T, Salabas E, Armagan A, Seckin S et al (2016) Duration of priapism is associated with increased corporal oxidative stress and antioxidant enzymes in a rat model. Andrologia 48:374–379. CrossRefGoogle Scholar
  25. 25.
    Evliyaoglu Y, Kayrin L, Kaya B (1997) Effect of allopurinol on lipid peroxidation induced in corporal tissue by veno-oclusive priapism in a rat model. Br J Urol 8:476–479. CrossRefGoogle Scholar
  26. 26.
    Sehirli AO, Sener G, Satiroglu H, Ayanoğlu-Dülger G (2003) Protective effect of N-acetylcysteine on renal ischemia/reperfusion injury in the rat. J Nephrol 16:75–80Google Scholar
  27. 27.
    Uluocak N, Atılgan D, Erdemir F et al (2010) An animal model of ischemic priapism and the effects of melatonin on antioxidant enzymes and oxidative injury parameters in rat penis. Int Urol Nephrol 42:889–895. CrossRefGoogle Scholar
  28. 28.
    Unsal V, Belge Kurutaş E (2017) Experimental hepatic carcinogenesis: oxidative stress and natural antioxidants. Open Access Maced J Med Sci 12:686–691. CrossRefGoogle Scholar
  29. 29.
    Bauer V, Sotníková R (2010) Nitric oxide – the endothelium-derived relaxing factor and its role in endothelial functions. Gen Physiol Biophys 29:319–340. CrossRefGoogle Scholar
  30. 30.
    Abdel Aziz MT, Motawi T, Rezq A et al (2012) Effects of a water-soluble curcumin protein conjugate vs. pure curcumin in a diabetic model of erectile dysfunction. J Sex Med 9:1815–1833. CrossRefGoogle Scholar
  31. 31.
    Işeri SO, Sener G, Saglam B, Gedik N, Ercan F, Yegen BC (2005) Oxytocin protects against sepsis-induced multiple organ damage: role of neutrophils. J Surg Res 126:73–81. CrossRefGoogle Scholar
  32. 32.
    Sehirli O, Sener E, Cetinel S, Yüksel M, Gedik N, Sener G (2008) Alpha-lipoic acid protects against renal ischaemia-reperfusion injury in rats. Clin Exp Pharmacol Physiol Suppl 35:249–255. CrossRefGoogle Scholar
  33. 33.
    Toklu H, Alican I, Ercan F, Sener G (2006) The beneficial effect of resveratrol on rat bladder contractility and oxidant damage following ischemia/reperfusion. Pharmacology 78:44–50. CrossRefGoogle Scholar
  34. 34.
    Gimpl G, Fahrenholz F (2001) The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81:629–683. CrossRefGoogle Scholar
  35. 35.
    Kiss A, Mikkelsen JD (2005) Oxytocin anatomy and functional assignments: a minireview. Endocr Regul 39:97–105Google Scholar
  36. 36.
    Erbas O, Anil Korkmaz HA, Oltulu F et al (2014) Oxytocin alleviates cisplatin-induced renal damage in rats. Iran J Basic Med Sci 17:747–752Google Scholar
  37. 37.
    Tas Hekimoğlu A, Toprak G, Akkoç H, Evliyaoglu O, Ozekinci S, Kelle I (2013) Oxytocin ameliorates remote liver injury induced by renal ischemia-reperfusion in rats. Korean J Physiol Pharmacol 17:169–173. CrossRefGoogle Scholar
  38. 38.
    Erkanli K, Erkanli Şentürk G, Aydın U et al (2013) Oxytocin protects rat skeletal muscle against ischemia/reperfusion injury. Ann Vasc Surg 27:662–670. CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2018

Authors and Affiliations

  1. 1.Department of UrologyTokat State HospitalTokatTurkey
  2. 2.Department of UrologyFethiye State HospitalFethiyeTurkey
  3. 3.Department of Urology, Faculty of MedicineGaziosmanpasa UniversityTokatTurkey
  4. 4.Mardin Artuklu University High School of Health and Central Research LaboratoryMardinTurkey

Personalised recommendations